Hudson Bay Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.96M | Buy |
105,000
+25,000
| +31% | +$1.18M | 0.02% | 391 |
|
|
2025
Q1 | $3.13M | Buy |
80,000
+72,500
| +967% | +$2.83M | 0.01% | 440 |
|
|
2024
Q4 | $406K | Buy |
+7,500
| New | +$406K | ﹤0.01% | 604 |
|
|
2024
Q3 | – | Sell |
-15,000
| Closed | -$660K | – | 773 |
|
|
2024
Q2 | $660K | Buy |
+15,000
| New | +$660K | ﹤0.01% | 513 |
|
|
2024
Q1 | – | Sell |
-15,000
| Closed | -$906K | – | 724 |
|
|
2023
Q4 | $906K | Buy |
+15,000
| New | +$906K | 0.01% | 452 |
|
|
2023
Q3 | – | Sell |
-60,000
| Closed | -$3.06M | – | 798 |
|
|
2023
Q2 | $3.06M | Buy |
+60,000
| New | +$3.06M | 0.02% | 369 |
|